Arcus Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcus Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q3 2024.
  • Arcus Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$105M, a 31.3% decline year-over-year.
  • Arcus Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$318M, a 1.55% increase year-over-year.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$340M, a 21.4% decline from 2022.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$280M, a 619% decline from 2021.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2021 was $54M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$318M -$105M -$25M -31.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$293M -$106M -$23M -27.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$270M -$16M +$70M +81.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$340M -$91M -$17M -23% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$323M -$80M -$10M -14.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$313M -$83M -$14M -20.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$299M -$86M -$19M -28.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$280M -$74M -$355M -126% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $75M -$70M +$8.14M +10.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $66.9M -$69M +$7.14M +9.37% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $59.7M -$67M +$5.75M +7.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $54M $281M +$333M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$279M -$78.1M -$79.7M -5135% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$199M -$76.1M -$30.8M -67.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$168M -$72.7M -$44.3M -156% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$124M -$51.8M -$34.3M -195% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$89.8M $1.55M +$24.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$115M -$45.4M -$16.2M -55.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$98.3M -$28.4M -$9.63M -51.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$88.7M -$17.5M -$4.04M -30% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$84.7M -$23.2M -$11.1M -91.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$73.6M -$29.2M -$13.3M -83.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$60.3M -$18.8M -$5.44M -40.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$54.9M -$13.5M -$141K -1.06% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$54.7M -$12.1M +$11M +47.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$65.7M -$15.9M -$6.24M -64.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$59.5M -$13.3M -$6.03M -82.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$53.4M -$13.3M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$23.1M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$9.66M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$7.3M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.